Conference
Mepolizumab for the treatment of refractory chronic cough with eosinophilic airways disease (MUCOSA): a randomized, double-blind, placebo-controlled trial
Authors
Diab N; Brister D; Kum E; Wahab M; Hassan W; Beaudin S; Stevens C; Wattie J; Wiltshire L; Howie K
Publisher
European Respiratory Society (ERS)
Publication Date
September 27, 2025
DOI
10.1183/13993003.congress-2025.oa2340
Name of conference
Airway pharmacology and treatment